FN1 and cancer: The mechanism of action of BCG is that the bacterial wall adheres to uroepithelial cells and bladder tumour cells by interacting with fibronectin, killing cancer cells directly; moreover, it initiates local intrinsic and specific immune responses in bladder tissue, killing cancer cells via immune‐mediated cytotoxicity.11